Cannabis Sales High in Michigan, but Research Barriers Persist
2026 cannabis research barriers limit clinical evidence despite high cannabis sales in Michigan. Federal restrictions create a gap impacting patient safety and treatment optimization. Clinicians face challenges advising patients without robust research…
How Psychedelics Came to Be Placed Under the Strictest International Control
Understanding the psychedelic drug regulatory history is essential as these compounds advance through FDA approval and clinical integration. The strict international control has created significant research barriers. This history shapes current patient…
US System For Classifying Marijuana And Other Drugs Does ‘Immense Damage,’ Former DEA Official Says
The controlled substances act scheduling system critically affects marijuana research and patient access. Former DEA officials highlight how this system creates barriers to clinical practice. Understanding these impacts is essential for anticipating…
Bridging the Regulatory Chasm in Investigator‐Initiated Cannabis Research
Investigator initiated cannabis research barriers limit clinical studies and evidence-based medicine. Regulatory challenges impede rigorous cannabis research needed for informed decisions. Understanding these barriers is key to advancing cannabis…